Admission Date: [**2122-9-24**]        Discharge Date: [**2122-10-1**]  Date of Birth:  [**2122-9-24**]        Sex:  F  Service:  NB   HISTORY OF PRESENT ILLNESS:  [**First Name4 (NamePattern1) **] [**Known lastname **], surname after discharge to be [**Doctor Last Name 1968**], is the former 3.435-kilogram  product of a term gestation pregnancy born to a 36-year-old G1/P0 woman.
A double nuchal cord was noted at the time of delivery.
The infant required bag-mask ventilation for birth apnea with good response.
On day of life #3, she was readmitted to the Neonatal Intensive Care Unit for low- grade fever and further concerns for sepsis.
GENERAL: Nondysmorphic term female in room air, no distress.
No nasal flaring.
CHEST: No retractions, mild tachypnea with agitation, no grunting, good bilateral breath sounds.
ABDOMEN: Soft, nondistended, no organomegaly, no masses, bowel sounds active, anus patent, umbilical cord drying without discharge or erythema.
She did have 1 spontaneous     episode of oxygen desaturation on day of life #4 that was     an isolated incident, and she has had no oxygen     desaturations or apnea in the 72 hours prior to     discharge.
CARDIOVASCULAR: [**Female First Name (un) **] has maintained normal heart rates     and blood pressures.
No murmurs have been noted.
INFECTIOUS DISEASE: As noted, [**Female First Name (un) **] was evaluated for     sepsis shortly after birth.
A complete blood count was     abnormal with an elevated band neutrophil count of 22%.
On day of life #3, with some     hypothermia she was again evaluated for sepsis and had a     repeat blood culture.
Due to the concern for     possible nonbacterial infection, a herpes simplex virus     PCR was sent and intravenous acyclovir was started.
Neither of the 2 blood cultures nor the     cerebrospinal bacterial culture fluid were positive.
Gentamicin levels had a peak of 10.5 mg/dL and a trough     of 1.5 mg/dL; that was repeated and was 0.9 mg/dL She had an IV extravasation with acyclovir and plastic surgeon was consulted and deemed to be superficial and only ointment needed to apply.
No medications.
No     notification of abnormal results to-date.
IMMUNIZATIONS RECOMMENDED:  Synagis RSV prophylaxis should be considered from [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the following 3 criteria: First, born at less than 32 weeks; second, born between 32 and 35 weeks with 2 of the following: Daycare during RSV season, a smoker in the household, neuromuscular disease, airway abnormalities, or school-age siblings; or third, with chronic lung disease.
Before this age and for the first 24 months of the child's life, immunization against influenza is recommended for household contacts and out of home caregivers.
Suspicion for bacterial sepsis ruled out.
Suspicion for herpes simplex virus infection ruled out.
